iCaRE Cancer Symposium

Leading researchers from across the metro area will discuss their research while students engaged in the Institute for Cancer Research and Education (iCaRE) will present their own work during the 2023 iCaRE Cancer Symposium: "Cancer Health Disparity: Diagnosis, Disease & Treatment."

Register to Attend

Either scan or click on the QR code to register to attend. 

Featured Speakers:

• Olorunseun Ogunwobi, MD. Ph.D., Hunter College
  Dr. Ogunwobi is the founding Director of the Hunter College Center for Cancer Health Disparities Research, Professor of Biological Sciences at Hunter College of The City University of New York, and a member of faculty in the Biology and Biochemistry Ph.D. programs at The Graduate Center of The City University of New York.  Ongoing studies include examination of the role of circulating tumor cell biology and epigenetics in the metastasis of solid cancers. Also, our laboratory is investigating the biological mechanisms underlying the racial disparities in specific solid cancers (hepatocellular carcinoma, pancreatic cancer, colon cancer, and prostate cancer). 
• Vikas Dukhande, Ph.D., St. John's University
  Dr. Dukhande Professor in Pharmacology in Department of Pharmaceutical Sciences in College of Pharmacy and Health Sciences. Currently, Dr. Dukhande’s lab is working on projects to find treatments for cancers such as glioblastoma and pancreatic cancer and also to study molecular mechanisms of insulin resistance involved in metabolic disorders such as diabetes. He is interested in deciphering the roles of post-translational modifications in governing these cellular processes. 
• Donita Brady, Ph.D., University of Pennsylvania
  Dr. Brady is the Harrison McCrea Dickson, M.D. and Clifford C. Baker, M.D. Presidential Associate Professor, Department of Cancer Biology, Assistant Dean for Inclusion, Diversity, and Equity in Research Training, Vice Chair for Inclusion and Equity, Department of Cancer Biology, Associate Investigator, Abramson Family Cancer Research Institute, Dr. Brady’s research program at Penn is founded in a new paradigm in nutrient sensing and protein regulation, termed metalloallostery, where redox-active metals control kinase activity, and is advancing our knowledge in basic science and disease-focused areas. The focus of her Lab’s research lies at the intersection of kinase signaling and copper (Cu) homeostasis with the goal of defining the mechanistic features of Cu-dependent kinases to target them in cancer via drug repurposing or development. 

Questions or Need More Information?

Manya Mascareno
Director, ICaRE
Phone: (516) 876-2737
E-mail: mascarenom@oldwestbury.edu